Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page
- CheckyesterdayChange DetectedThe study record for the ixekizumab bullous pemphigoid trial is no longer displayed, and the page shows a 403 Forbidden message with a Home link.SummaryDifference19%

- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the Ixekizumab bullous pemphigoid study is now displayed, with study details, participation criteria, treatment plan, outcome measures, and related documents and links.SummaryDifference53%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision tag (v3.7.0) has been added to the page, signaling an update to the study record's version. This reflects a metadata update rather than changes to the study details.SummaryDifference19%

- Check50 days agoChange DetectedThe page revision number was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s version. This update appears to be a non-substantive administrative change rather than a modification to study details or eligibility criteria.SummaryDifference0.1%

- Check71 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, signaling a backend update to the site’s template or CMS without altering study content or visible functions.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a system update rather than changes to the study content. No study data or user-facing content appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.